Lars Hedbys

Partner at Ventac Partners

Lars Hedbys is the Chairman of the Board at Chosa Oncology and Strominnate Therapeutics AB. Additionally, Lars serves as a Board Member at Xintela AB, Asgard Therapeutics, and Cell Invent AB. Lars is also a Member of the Board at RhoVac and a Partner at Ventac Partners, a life science consulting firm. With a Ph.D. in Applied Biochemistry from Lund University and a M.Sc. in Chemical Engineering from Chalmers University of Technology, Lars Hedbys has a strong background in the life science industry and brings valuable expertise to the companies Lars is involved with.

Location

Lund, Sweden

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices